Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes

Diabetes Care - United States
doi 10.2337/dcs15-3007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects With Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Clinical Importance of Evidence Based Therapy for Diabetes Type 2

Saudi Journal of Internal Medicine
2012English

Rationale and Options for Combination Therapy in the Treatment of Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Myocardial Considerations in Type 2 Diabetes: 2018

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2013English

Combination of Empagliflozin and Metformin Therapy: A Consideration of Its Place in Type 2 Diabetes Therapy

Clinical Medicine Insights: Endocrinology and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
2000English

Clinical Use of Continuous Glucose Monitoring in Adults With Type 2 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy